Kyprolis and Stroke - a phase IV clinical study of FDA data

Summary:

Stroke is reported as a side effect among people who take Kyprolis (carfilzomib), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Revlimid, and have Drug abuse.

The phase IV clinical study analyzes which people have Stroke when taking Kyprolis. It is created by eHealthMe based on reports of 15,068 people who have side effects when taking Kyprolis from the FDA, and is updated regularly.

What is Kyprolis?

Kyprolis has active ingredients of carfilzomib. It is often used in multiple myeloma. eHealthMe is studying from 15,080 Kyprolis users. Check the latest studies of Kyprolis.

What is Stroke?

Stroke (sudden death of a portion of the brain cells due to a lack of oxygen) is found to be associated with 2,401 drugs and 3,006 conditions by eHealthMe. Check the latest studies of Stroke.

On Aug, 23, 2025

15,068 people reported to have side effects when taking Kyprolis.
Among them, 67 people (0.44%) have Stroke.

Among these 67 people:

How long have people been on Kyprolis when they have Stroke? *

What is the gender of people who have Stroke when taking Kyprolis? *

female: 52.46 %
male: 47.54 %

What is the age of people who have Stroke when taking Kyprolis? *

What are other drugs people take besides Kyprolis? *

What are other side effects people have besides Stroke? *

Death: 6 people, 8.96%
Fatigue (feeling of tiredness): 4 people, 5.97%
Nausea (feeling of having an urge to vomit): 4 people, 5.97%
Drug Ineffective: 4 people, 5.97%
High Blood Pressure: 3 people, 4.48%
Heart Attack: 3 people, 4.48%
Nosebleed (bleeding from nose): 3 people, 4.48%
Speech Impairment (Adult) (inability to speak (adult)): 3 people, 4.48%
Memory Loss: 3 people, 4.48%
Thrombocytopenia (decrease of platelets in blood): 3 people, 4.48%

What are the existing conditions these people have? *

Drug Abuse: 3 people, 4.48%
Prostate Cancer Metastatic: 2 people, 2.99%
Wheezing (a high-pitched whistling sound made while you breath): 1 person, 1.49%
Meningitis (inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges): 1 person, 1.49%
Dyspnea (difficult or laboured breathing): 1 person, 1.49%
High Blood Cholesterol: 1 person, 1.49%
High Blood Pressure: 1 person, 1.49%
Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 1 person, 1.49%
Insomnia (sleeplessness): 1 person, 1.49%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 1 person, 1.49%

* Approximation only. Some reports may have incomplete information.

Do you take Kyprolis and have Stroke?

- Check whether Stroke is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Kyprolis:

Kyprolis (15,080 reports)

Stroke treatments and more:

Stroke (334,630 reports)

How severe was Stroke and when was it recovered:

Stroke in Kyprolis

Browse all side effects of Kyprolis:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Stroke:

Stroke (2,401 drugs)

Browse all the conditions that are associated with Stroke:

Stroke (3,006 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on carfilzomib (the active ingredients of Kyprolis) and Kyprolis (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.